EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
about
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and BtkIs now the time for molecular driven therapy for diffuse large B-cell lymphoma?Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center.CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.Outcomes among US patients with diffuse large B cell lymphoma are independent of tumor Epstein Barr virus positivity or immunosuppression.EBV transformation induces overexpression of hMSH2/3/6 on B lymphocytes and enhances γδT-cell-mediated cytotoxicity via TCR and NKG2D.Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma
P2860
Q35880791-510F86F4-5C36-4100-A455-7CE1A8C67FB1Q35953524-41B2C375-4543-4807-B718-FDBFC51A6B71Q35987244-E6517B9B-453B-4166-9D86-E5D7DF0D2E22Q37706355-1310E22D-8F6B-4984-BAE7-8892713834D3Q38656983-EDD031D1-0E09-4770-AAD7-5C1BED85D759Q38720593-6CBFD561-16A8-40D4-B0C6-E5DCC833EA9CQ38812004-2DAAFB7F-4AE9-4106-B236-D06FAA1CE3C9Q40052180-1F02F99F-60F8-4A36-8AFA-86B6693C4B76Q40150053-8B5E2E90-A602-4163-9E32-57881C0F3E05Q40250056-119460DA-8E1B-418B-9135-7B77721D7268Q40696036-6DDF6114-6ED4-41FC-82EE-C59C7A2C72F5Q41000926-ACE7098C-088F-4E57-B9BC-53084CBDD839Q45324330-46FE4F3B-A9B5-479E-9A2A-578D20E29263Q52669885-060267B8-D73A-49FC-B17A-4D14A889FAC1Q55426973-F5B3CB05-DF12-4DF9-8429-1B47C9E76976Q55710335-20B3FC5A-287F-4338-B576-E8FC6EC86CECQ58783385-BB1BFA02-6689-466A-94A4-178C30F748E4
P2860
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
EBV-positive diffuse large B-c ...... his a distinct disease entity?
@en
type
label
EBV-positive diffuse large B-c ...... his a distinct disease entity?
@en
prefLabel
EBV-positive diffuse large B-c ...... his a distinct disease entity?
@en
P2093
P2860
P356
P1433
P1476
EBV-positive diffuse large B-c ...... his a distinct disease entity?
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDU556
P577
2014-12-04T00:00:00Z